Pharmacist-led, technology-assisted study to improve medication safety, cardiovascular risk factor control, and racial disparities in kidney transplant recipients-Reference-Cited by-同舟云学术

Pharmacist-led, technology-assisted study to improve medication safety, cardiovascular risk factor control, and racial disparities in kidney transplant recipients

Published:2018-07-03 Issue:2 Volume:1 Page:81-88
ISSN:2574-9870
Container-title:Journal of the American College of Clinical Pharmacy
language:en
Short-container-title:J Am Coll Clin Pharm

Author:

Taber David J.¹²^ORCID,Gebregziabher Mulugeta³,Posadas Aurora⁴,Schaffner Caitlin¹,Egede Leonard E.⁵,Baliga Prabhakar K.⁶

Affiliation:

1. Division of Transplant Surgery, College of Medicine; Medical University of South Carolina; Charleston South Carolina

2. Department of Pharmacy Services; Ralph H Johnson VAMC; Charleston South Carolina

3. Department of Public Health Sciences, College of Medicine; Medical University of South Carolina; Charleston South Carolina

4. Division of Transplant Nephrology, College of Medicine; Medical University of South Carolina; Charleston South Carolina

5. Division of General Internal Medicine; Medical College of Wisconsin; Milwaukee Wisconsin

6. Department of Surgery, College of Medicine; Medical University of South Carolina; Charleston South Carolina

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jac5.1024/fullpdf

Reference42 articles.

1. Reduced racial disparity in kidney transplant outcomes in the United States from 1990 to 2012;Purnell;J Am Soc Nephrol,2016

2. Twenty years of evolving trends in racial disparities for adult kidney transplant recipients;Taber;Kidney Int,2016

3. The use of daclizumab, tacrolimus and mycophenolate mofetil in African-American and Hispanic first renal transplant recipients;Ciancio;Am J Transplant,2003

4. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group;Neylan;Transplantation,1998

5. Sirolimus improves the two-year outcome of renal allografts in African-American patients;Podder;Transplant Int,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifaceted Intervention To Improve Graft outcome disparities in African American Kidney Transplants: MITIGAAT Study Protocol (Preprint);JMIR Research Protocols;2024-02-27

2. Multifaceted Intervention To Improve Graft outcome disparities in African American Kidney Transplants: MITIGAAT Study Protocol (Preprint);2024-02-27

3. Results of a multicenter cluster-randomized controlled clinical trial testing the effectiveness of a bioinformatics-enabled pharmacist intervention in transplant recipients;American Journal of Transplantation;2023-12

4. A Randomized Control Trial Testing a Medication Safety Dashboard in Veteran Transplant Recipients;Progress in Transplantation;2023-04-11

5. Effectiveness of mHealth Interventions for Blood Pressure Control among Vulnerable Populations: A Systematic Review;2023-04-10